Načítá se...
Vancomycin AUC(24)/MIC Ratio in Patients with Methicillin‐Resistant Staphylococcus aureus Pneumonia
BACKGROUND: Vancomycin is the treatment of choice for serious methicillin‐resistant Staphylococcus aureus (MRSA) infections. The area under the concentration–time curve from 0 to 24 hr (AUC(24))/minimum inhibitory concentration (MIC) ratio was recently introduced as a parameter for assessing clinica...
Uloženo v:
| Vydáno v: | J Clin Lab Anal |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6807131/ https://ncbi.nlm.nih.gov/pubmed/26499918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21883 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|